Latest total revenue for SRTS: $18M, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest total revenue for SRTS is $18M as of June 2026. That compares with $38M in the prior-year period — down 53.4% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Sensus Healthcare's historical trend and sector peers before judging valuation or financial health.
Over the past year, SRTS's total revenue moved from $38M to $18M — a 53.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sensus Healthcare's operating scale or balance-sheet position.
Against Healthcare companies, SRTS currently prints $18M for total revenue, while the sector average sits near $110B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Sensus Healthcare's growth, margins, and balance sheet.
A total revenue figure of $18M for SRTS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.
After noting SRTS's total revenue ($18M), review year-over-year change from $38M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.